{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:15:43Z","timestamp":1778134543883,"version":"3.51.4"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute myocardial injury is a frequent and severe complication of COVID-19, contributing to increased mortality. This study investigates the role of chymase-positive mast cells (MCs) in myocardial damage among patients who died from severe or critical COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cardiac tissue samples from 60 deceased patients were analyzed histologically and immunohistochemically to assess MC density, degranulation status, and associated fibrotic remodeling. Clinical and laboratory parameters, including troponin I levels and inflammatory markers were obtained during hospitalization period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The findings revealed a low overall density of cardiac MCs, with a predominance of degranulated chymase-positive cells. These MCs were significantly correlated with indicators of severe COVID-19 progression, such as neutrophilic leukocytosis, elevated band neutrophils, monocytosis, and increased erythrocyte sedimentation rate. A strong association was also observed between chymase-positive MCs and elevated troponin I levels, the association between troponin I and degranulating chymase-positive MC density remained statistically significant after multivariable adjustment, supporting an independent link to myocardial injury. Additionally, increased MC presence coincided with extensive interstitial and perivascular fibrosis, marked by a predominance of type III collagen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results support the hypothesis that chymase-positive MCs contribute to myocardial inflammation and fibrosis in the context of COVID-19. Understanding their role may open avenues for targeted therapies aimed at mitigating cardiac complications in future coronavirus-related diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1816510","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:41:03Z","timestamp":1778132463000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Engagement of chymase-positive mast cells in myocardial damage associated with COVID-19"],"prefix":"10.3389","volume":"13","author":[{"given":"Andrey V.","family":"Budnevsky","sequence":"first","affiliation":[{"name":"Department of Faculty Therapy, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey N.","family":"Avdeev","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University)","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina D.","family":"Arkhipova","sequence":"additional","affiliation":[{"name":"Department of Faculty Therapy, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djuro","family":"Kosanovic","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University)","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria V.","family":"Shishkina","sequence":"additional","affiliation":[{"name":"Department of Histology, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]},{"name":"Scientific Research Institute of Experimental Biology and Medicine, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana A.","family":"Chernik","sequence":"additional","affiliation":[{"name":"Department of Faculty Therapy, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeniy S.","family":"Ovsyannikov","sequence":"additional","affiliation":[{"name":"Department of Faculty Therapy, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna M.","family":"Perveeva","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Experimental Biology and Medicine, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey A.","family":"Filin","sequence":"additional","affiliation":[{"name":"Department of Pathological Anatomy, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]},{"name":"Voronezh Regional Pathoanatomical Bureau","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman E.","family":"Tokmachev","sequence":"additional","affiliation":[{"name":"Department of Faculty Therapy, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]},{"name":"Scientific Research Institute of Experimental Biology and Medicine, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Pertsev","sequence":"additional","affiliation":[{"name":"Department of Faculty Therapy, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena E.","family":"Ivanova","sequence":"additional","affiliation":[{"name":"Department of Histology, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana V.","family":"Samoylenko","sequence":"additional","affiliation":[{"name":"Department of Histology, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]},{"name":"Scientific Research Institute of Experimental Biology and Medicine, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyubov N.","family":"Antakova","sequence":"additional","affiliation":[{"name":"Scientific Research Institute of Experimental Biology and Medicine, Burdenko Voronezh State Medical University","place":["Voronezh, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/clc.23540","article-title":"Prevalence and impact of cardiac injury on COVID-19: a systematic review and meta-analysis","volume":"44","author":"Fu","year":"2021","journal-title":"Clin Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/tcmj.tcmj_219_22","article-title":"Coronavirus disease 2019 and cardiovascular disease","volume":"35","author":"Song","year":"2023","journal-title":"Tzu Chi Med J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"818890","DOI":"10.3389\/fcvm.2022.818890","article-title":"The role of interleukin-6 family members in cardiovascular diseases","volume":"9","author":"Feng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12931-022-02284-3","article-title":"Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients","volume":"23","author":"Budnevsky","year":"2022","journal-title":"Respir Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.virs.2024.03.001","article-title":"Mast cell degranulation-triggered by SARS-CoV-2 induces tracheal-bronchial epithelial inflammation and injury","volume":"39","author":"Cao","year":"2024","journal-title":"Virol Sin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/cells13080711","article-title":"Involvement of mast cells in the pathology of COVID-19: clinical and laboratory parallels","volume":"13","author":"Budnevsky","year":"2024","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.21103\/Article12(2)_RA1","article-title":"Possible unexplored aspects of COVID-19 pathogenesis: the role of carboxypeptidase A3","volume":"12","author":"Budnevsky","year":"2022","journal-title":"Int J Biomed"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/cvr\/cvae066","article-title":"Mast cells: a novel therapeutic avenue for cardiovascular diseases?","volume":"120","author":"Poto","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-1-4939-1568-2_8","article-title":"The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling","volume":"1220","author":"Janicki","year":"2015","journal-title":"Methods Mol Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.23868\/202110004","article-title":"Biogenesis and secretory pathways of mast cell chymase: structural and functional aspects","volume":"16","author":"Atiakshin","year":"2021","journal-title":"Genes Cells"},{"key":"B12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1291\/hypres.28.457","article-title":"Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats","volume":"28","author":"Kirimura","year":"2005","journal-title":"Hypertens Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.57256\/2949-0715-2024-3-71-82","article-title":"The influence of tissue angiotensins on elements of the cardiovascular system (lecture 2)","volume":"3","author":"Gutsol","year":"2024","journal-title":"Baikal Med J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/1346-8138.13234","article-title":"Mast cell chymase in experimentally induced psoriasis","volume":"43","author":"Suttle","year":"2016","journal-title":"J Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/cvr\/cvr147","article-title":"Contributions of ACE and mast cell chymase to endogenous angiotensin II generation and leucocyte recruitment in vivo","volume":"92","author":"Company","year":"2011","journal-title":"Cardiovasc Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/bjd.17534","article-title":"Mast cell chymase degrades fibrinogen and fibrin","volume":"181","author":"Lipits\u00e4","year":"2019","journal-title":"Br J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3389\/fimmu.2017.00846","article-title":"The mast cell, contact, and coagulation system connection in anaphylaxis","volume":"8","author":"Guilarte","year":"2017","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.pharmthera.2006.05.008","article-title":"Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models","volume":"112","author":"Miyazaki","year":"2006","journal-title":"Pharmacol Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e94732","DOI":"10.1371\/journal.pone.0094732","article-title":"Chymase mediates injury and mitochondrial damage in cardiomyocytes during acute ischemia\/reperfusion in the dog","volume":"9","author":"Zheng","year":"2014","journal-title":"PLoS One"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1816510\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:41:05Z","timestamp":1778132465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1816510\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":20,"alternative-id":["10.3389\/fcvm.2026.1816510"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1816510","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"article-number":"1816510"}}